• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Regucalcin, a multifunctional protein: its role on pathogenesis of disease onset

Research Project

Project/Area Number 19K07092
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 47030:Pharmaceutical hygiene and biochemistry-related
Research InstitutionMeijo University

Principal Investigator

Murata Tomiyasu  名城大学, 薬学部, 教授 (80285189)

Project Period (FY) 2019-04-01 – 2022-03-31
Project Status Completed (Fiscal Year 2021)
Budget Amount *help
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2021: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2020: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2019: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Keywordsレギュカルチン / 肥満症 / 糖尿病 / 癌 / 神経変性疾患 / 骨粗鬆症
Outline of Research at the Start

申請者は,レギュカルチン(regucalcin)が「癌細胞の増殖抑制作用」「神経細胞の保護作用」「脂肪分化の促進作用」「骨芽細胞の分化抑制作用と破骨細胞の分化促進作用」を有することを見出し,レギュカルチンの細胞調節機能に関する研究を進めている.本研究では,疾患発症メカニズムを解明するために,レギュカルチンの病態生理的役割を考慮して,レギュカルチンの機能異常が癌,神経変性疾患,肥満症,骨粗鬆症の発症につながることを明らかにしたいと考えている.さらに,レギュカルチンを標的とした疾患治療法の確立に向けた基礎研究も実施したいと考えている.

Outline of Final Research Achievements

(1) In a transwell co-culture system, RGN overexpression in adipocytes blocked inflammatory crosstalk between 3T3-L1 adipocytes and macrophages. RGN may act as a suppressor of inflammation in macrophage-infiltrated adipocyte tissue. In addition, in co-cultures of pancreaticβ-cells with macrophages, induction of RGN expression by novel chemical compound in macrophages attenuated apoptosis in pancreaticβ-cells. The chemical inducer of RGN, might be useful for developing a new drug against macrophage-associated β-cell inflammation. (2) The prolonged survival of patients with renal cancer and prostate cancer are concomitant with a higher regucalcin gene expression in tumor tissues. Overexpression of regucalcin suppresses the growth of human renal cell carcinoma cells and prostate cancer cells in vitro. (3) It is known that the formation of stress granules is related to pathogenesis of neurodegenerative diseases. Regucalcin regulated the formation of stress granules in neuronal cells.

Academic Significance and Societal Importance of the Research Achievements

(1)RGNがマクロファージを介した脂肪細胞の炎症反応を抑制したことは,RGNを標的とした肥満症の新しい治療法の開発につながると考えられる.さらに,RGNがマクロファージを介した膵β細胞のアポトーシス細胞死を抑制したことは,RGNを基軸とした肥満性糖尿病の新しい分子病態機構を提唱することができた.(2)RGNが癌細胞の増殖を抑制する生体内因子であることを発見したことは,RGNを基軸とした癌治療を見据えた基礎研究が可能になった.(3)RGNが神経細胞のストレス顆粒の形成に関与していたことは,神経変性疾患の発症に対してRGNがストレス防御因子として機能するという新しい概念を提唱することができた.

Report

(4 results)
  • 2021 Annual Research Report   Final Research Report ( PDF )
  • 2020 Research-status Report
  • 2019 Research-status Report
  • Research Products

    (24 results)

All 2022 2021 2020 2019 Other

All Int'l Joint Research (3 results) Journal Article (12 results) (of which Int'l Joint Research: 10 results,  Peer Reviewed: 12 results,  Open Access: 3 results) Presentation (9 results)

  • [Int'l Joint Research] ハワイ大学がんセンター(米国)

    • Related Report
      2021 Annual Research Report
  • [Int'l Joint Research] ハワイ大学がんセンター(米国)

    • Related Report
      2020 Research-status Report
  • [Int'l Joint Research] University of Hawaii cancer center(米国)

    • Related Report
      2019 Research-status Report
  • [Journal Article] Chemical inducer of regucalcin attenuates lipopolysaccharide‐induced inflammatory responses in pancreatic MIN6 β‐cells and RAW264.7 macrophages2021

    • Author(s)
      Murata Tomiyasu、Hashimoto Kazunori、Kohno Susumu、Takahashi Chiaki、Yamaguchi Masayoshi、Ito Chihiro、Masataka Itoigawa、Kojima Roji、Hikita Kiyomi、Kaneda Norio
    • Journal Title

      FEBS Open Bio

      Volume: 12 Issue: 1 Pages: 175-191

    • DOI

      10.1002/2211-5463.13321

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] The phytochemical p-hydroxycinnamic acid suppresses the growth and stimulates the death in human liver cancer HepG2 cells2021

    • Author(s)
      Yamaguchi Masayoshi、Murata Tomiyasu、Ramos Joe W.
    • Journal Title

      Anticancer Drugs

      Volume: 32 Issue: 5 Pages: 558-566

    • DOI

      10.1097/cad.0000000000001059

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] The botanical component p-hydroxycinnamic acid suppresses the growth and bone metastatic activity of human prostate cancer PC-3 cells in vitro2021

    • Author(s)
      Yamaguchi Masayoshi、Murata Tomiyasu、Ramos Joe W.
    • Journal Title

      Journal of Cancer Research and Clinical Oncology

      Volume: 147 Issue: 2 Pages: 339-350

    • DOI

      10.1007/s00432-020-03405-5

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Progression-free survival of prostate cancer patients is prolonged with a higher regucalcin expression in the tumor tissues: Overexpressed regucalcin suppresses the growth and bone activity in human prostate cancer cells2021

    • Author(s)
      Yamaguchi Masayoshi、Osuka Satoru、Murata Tomiyasu、Ramos Joe W.
    • Journal Title

      Translational Oncology

      Volume: 14 Issue: 1 Pages: 100955-100955

    • DOI

      10.1016/j.tranon.2020.100955

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Overexpression of Regucalcin Suppresses the Growth of Human Osteosarcoma Cells in?Vitro: Repressive Effect of Extracellular Regucalcin2020

    • Author(s)
      Yamaguchi Masayoshi、Murata Tomiyasu
    • Journal Title

      Cancer Investigation

      Volume: 38 Issue: 1 Pages: 37-51

    • DOI

      10.1080/07357907.2019.1708924

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] The calcium channel agonist Bay K 8644 promotes the growth of human liver cancer HepG2 cells in vitro: suppression with overexpressed regucalcin2020

    • Author(s)
      Yamaguchi Masayoshi、Murata Tomiyasu、Ramos Joe W.
    • Journal Title

      Molecular and Cellular Biochemistry

      Volume: 472 Issue: 1-2 Pages: 173-185

    • DOI

      10.1007/s11010-020-03795-7

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Regucalcin enhances adipocyte differentiation and attenuates inflammation in 3T3‐L1 cells2020

    • Author(s)
      Murata Tomiyasu、Yamaguchi Masayoshi、Kohno Susumu、Takahashi Chiaki、Risa Watanabe、Hatori Kanna、Hikita Kiyomi、Kaneda Norio
    • Journal Title

      FEBS Open Bio

      Volume: 10 Issue: 10 Pages: 1967-1984

    • DOI

      10.1002/2211-5463.12947

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Extracellular regucalcin suppresses colony formation and growth independent of tumor suppressor p53 in human mammary epithelial cells2020

    • Author(s)
      Yamaguchi Masayoshi、Murata Tomiyasu
    • Journal Title

      Tissue and Cell

      Volume: 67 Pages: 101447-101447

    • DOI

      10.1016/j.tice.2020.101447

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Cytotoxic activity of dimeric acridone alkaloids derived from Citrus plants towards human leukaemia HL-60 cells2020

    • Author(s)
      Murata Tomiyasu、Kohno Susumu、Ogawa Kazuma、Ito Chihiro、Itoigawa Masataka、Ito Masafumi、Hikita Kiyomi、Kaneda Norio
    • Journal Title

      Journal of Pharmacy and Pharmacology

      Volume: 72 Issue: 10 Pages: 1445-1457

    • DOI

      10.1111/jphp.13327

    • Related Report
      2020 Research-status Report
    • Peer Reviewed
  • [Journal Article] Induction of enantio-selective apoptosis in human leukemia HL-60 cells by (S)-erypoegin K, an isoflavone isolated from Erythrina poeppigiana2020

    • Author(s)
      Hikita Kiyomi、Saigusa Satomi、Takeuchi Yuto、Matsuyama Haruka、Nagai Rina、Kato Kuniki、Murata Tomiyasu、Tanaka Hitoshi、Wagh Yogesh S.、Asao Naoki、Kaneda Norio
    • Journal Title

      Bioorganic & Medicinal Chemistry

      Volume: 28 Issue: 11 Pages: 115490-115490

    • DOI

      10.1016/j.bmc.2020.115490

    • Related Report
      2020 Research-status Report
    • Peer Reviewed
  • [Journal Article] Prolonged survival of renal cancer patients is concomitant with a higher regucalcin gene expression in tumor tissues: Overexpression of regucalcin suppresses the growth of human renal cell carcinoma cells in vitro2019

    • Author(s)
      Yamaguchi Masayoshi、Osuka Satoru、Hankinson Oliver、Murata Tomiyasu
    • Journal Title

      International Journal of Oncology

      Volume: 54 Pages: 188-198

    • DOI

      10.3892/ijo.2018.4611

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] EPHB6 controls catecholamine biosynthesis by up-regulating tyrosine hydroxylase transcription in adrenal gland chromaffin cells2019

    • Author(s)
      Shi W, Wang Y, Peng J, Qi S, Vitale N, Kaneda N, Murata T, Luo H, Wu J
    • Journal Title

      Journal of Biological Chemistry

      Volume: 294 Issue: 17 Pages: 6871-6887

    • DOI

      10.1074/jbc.ra118.005767

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Presentation] Regucalcinによるamyloid-β毒性に対する細胞保護効果2022

    • Author(s)
      都築奈々夏、橋本和宜、村田富保
    • Organizer
      日本薬学会第142年会
    • Related Report
      2021 Annual Research Report
  • [Presentation] ヒト骨肉腫細胞株における分泌型Regucalcinの細胞増殖抑制効果2022

    • Author(s)
      堀尾麻友香、橋本和宜、村田富保
    • Organizer
      日本薬学会第142年会
    • Related Report
      2021 Annual Research Report
  • [Presentation] レギュカルチン誘導性の細胞増殖抑制機構におけるp53の役割2022

    • Author(s)
      林玲奈、橋本和宜、村田富保
    • Organizer
      日本薬学会第142年会
    • Related Report
      2021 Annual Research Report
  • [Presentation] 脂肪細胞の炎症性変化におけるRegucalcinの役割2022

    • Author(s)
      廣瀬優、橋本和宜、村田富保
    • Organizer
      日本薬学会第142年会
    • Related Report
      2021 Annual Research Report
  • [Presentation] レギュカルチンによる脂肪細胞分化制御2021

    • Author(s)
      橋本和宜、堀尾麻友香、村田富保
    • Organizer
      第67回日本薬学会東海支部大会
    • Related Report
      2021 Annual Research Report
  • [Presentation] 骨肉腫細胞株におけるレギュカルチン誘導性細胞増殖抑制2021

    • Author(s)
      堀尾麻友香、林玲奈、橋本和宜、村田富保
    • Organizer
      第67回日本薬学会東海支部大会
    • Related Report
      2021 Annual Research Report
  • [Presentation] レギュカルチンによる癌抑制遺伝子p53非依存性細胞増殖抑制2021

    • Author(s)
      林玲奈、小林愛、橋本和宜、村田富保
    • Organizer
      第67回日本薬学会東海支部大会
    • Related Report
      2021 Annual Research Report
  • [Presentation] レギュカルチンによる脂肪細胞の炎症制御2021

    • Author(s)
      橋本和宜、村田富保
    • Organizer
      第44回日本分子生物学会年会
    • Related Report
      2021 Annual Research Report
  • [Presentation] リポポリサッカライドによって惹起される炎症反応に対するregucalcinの抑制効果2019

    • Author(s)
      村田 富保、河野晋、高橋智聡、疋田清美、金田 典雄
    • Organizer
      第42回日本分子生物学会年会
    • Related Report
      2019 Research-status Report

URL: 

Published: 2019-04-18   Modified: 2024-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi